180 related articles for article (PubMed ID: 18081569)
1. Analysis of primary prevention services for cardiovascular disease in Australia's community pharmacies.
Joyce A; Berbatis CG; Sunderland VB; Dhaliwal SS
Aust N Z J Public Health; 2007 Dec; 31(6):516-9. PubMed ID: 18081569
[TBL] [Abstract][Full Text] [Related]
2. Analysis of enhanced pharmacy services in rural community pharmacies in Western Australia.
Wibowo Y; Berbatis C; Joyce A; Sunderland VB
Rural Remote Health; 2010; 10(3):1400. PubMed ID: 20684656
[TBL] [Abstract][Full Text] [Related]
3. Providing patient care in community pharmacies in Australia.
Benrimoj SI; Roberts AS
Ann Pharmacother; 2005 Nov; 39(11):1911-7. PubMed ID: 16219897
[TBL] [Abstract][Full Text] [Related]
4. A pilot study evaluating multiple risk factor interventions by community pharmacists to prevent cardiovascular disease: the PAART CVD pilot project.
McNamara KP; O'Reilly SL; Dunbar JA; Bailey MJ; George J; Peterson GM; Jackson SL; Janus ED; Bunker S; Duncan G; Howarth H
Ann Pharmacother; 2012 Feb; 46(2):183-91. PubMed ID: 22318928
[TBL] [Abstract][Full Text] [Related]
5. Health promotion and screening services reported by older adult patients of urban primary care physicians.
Love RR; Davis JE; Mundt M; Clark C
J Fam Pract; 1997 Aug; 45(2):142-50. PubMed ID: 9267373
[TBL] [Abstract][Full Text] [Related]
6. The role of policy in community pharmacies' response to injection-drug use: results of a nationwide Canadian survey.
Myers T; Cockerill R; Millson M; Rankin J; Worthington C
AIDS Public Policy J; 1996; 11(2):78-88. PubMed ID: 10915241
[TBL] [Abstract][Full Text] [Related]
7. Provision of primary care to patients with chronic cough in the community pharmacy setting.
Schneider CR; Everett AW; Geelhoed E; Kendall PA; Murray K; Garnett P; Salama M; Clifford RM
Ann Pharmacother; 2011 Mar; 45(3):402-8. PubMed ID: 21325099
[TBL] [Abstract][Full Text] [Related]
8. Hypertensive patients' use of blood pressure monitors stationed in pharmacies and other locations: a cross-sectional mail survey.
Viera AJ; Cohen LW; Mitchell CM; Sloane PD
BMC Health Serv Res; 2008 Oct; 8():216. PubMed ID: 18945355
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of interventions to prevent cardiovascular disease in Australia's indigenous population.
Ong KS; Carter R; Vos T; Kelaher M; Anderson I
Heart Lung Circ; 2014 May; 23(5):414-21. PubMed ID: 24252448
[TBL] [Abstract][Full Text] [Related]
10. HIV prevention and drug treatment services for drug misusers: a national study of community pharmacists' attitudes and their involvement in service specific training.
Sheridan J; Strang J; Taylor C; Barber N
Addiction; 1997 Dec; 92(12):1737-48. PubMed ID: 9581006
[TBL] [Abstract][Full Text] [Related]
11. Consumer satisfaction with community pharmacies in Warri, Nigeria.
Oparah AC; Kikanme LC
Res Social Adm Pharm; 2006 Dec; 2(4):499-511. PubMed ID: 17161808
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical care in community pharmacies: practice and research in Canada.
Jones EJ; Mackinnon NJ; Tsuyuki RT
Ann Pharmacother; 2005 Sep; 39(9):1527-33. PubMed ID: 16014374
[TBL] [Abstract][Full Text] [Related]
13. Pharmacy characteristics associated with the provision of drug therapy services in nonmetropolitan community pharmacies.
Gadkari AS; Mott DA; Kreling DH; Bonnarens JK
J Rural Health; 2009; 25(3):290-5. PubMed ID: 19566615
[TBL] [Abstract][Full Text] [Related]
14. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
Kang HY; Ko SK; Liew D
Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
[TBL] [Abstract][Full Text] [Related]
15. Providing patient care in community pharmacies in Spain.
Gastelurrutia MA; Faus MJ; Fernández-Llimós F
Ann Pharmacother; 2005 Dec; 39(12):2105-10. PubMed ID: 16288077
[TBL] [Abstract][Full Text] [Related]
16. Change in public satisfaction with community pharmacy services in Tartu, Estonia, between 1993 and 2005.
Volmer D; Bell JS; Janno R; Raal A; Hamilton DD; Airaksinen MS
Res Social Adm Pharm; 2009 Dec; 5(4):337-46. PubMed ID: 19962677
[TBL] [Abstract][Full Text] [Related]
17. Patients' value of asthma services in Australian pharmacies: the way ahead for asthma care.
Naik-Panvelkar P; Armour C; Rose J; Saini B
J Asthma; 2012 Apr; 49(3):310-6. PubMed ID: 22348432
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical care in community pharmacies: practice and research in Germany.
Eickhoff C; Schulz M
Ann Pharmacother; 2006 Apr; 40(4):729-35. PubMed ID: 16569798
[TBL] [Abstract][Full Text] [Related]
19. Collaborative services among community pharmacies for patients with diabetes.
Storimans MJ; Klungel OH; Talsma H; Bouvy ML; de Blaey CJ
Ann Pharmacother; 2005 Oct; 39(10):1647-53. PubMed ID: 16144877
[TBL] [Abstract][Full Text] [Related]
20. Screening for sleep disorders in community pharmacies--evaluation of a campaign in Switzerland.
Hersberger KE; Renggli VP; Nirkko AC; Mathis J; Schwegler K; Bloch KE
J Clin Pharm Ther; 2006 Feb; 31(1):35-41. PubMed ID: 16476118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
